Navigation Links
Covaris Introduces DNA Shearing Service
Date:4/2/2009

WOBURN, Mass., April 2 /PRNewswire/ -- Covaris Incorporated today announced the introduction of DNA shearing service using Covaris instruments and technology.

Over the past few years, Covaris instruments have become the gold standard for DNA shearing application, as a sample preparation step for next generation sequencing. The Covaris process is validated and compatible with all next-gen sequencing platforms. This process is highly reproducible and gives narrow size distribution. The isothermal, non-contact processing, in closed vessels, results in high recovery and no cross contamination, which are critical for any sequencing applications downstream.

"With the launch of our DNA shearing service, researchers can immediately take advantage of our technology without having to purchase the instrument first," said Jim Laugharn, President and CEO of Covaris, "the service is ideal for several groups of customers--those who only need to process small amount of samples periodically; those who are waiting for capital budget approval for instrument purchase, and those who just want to evaluate the technology without long-term commitment. For these investigators, the DNA shearing service is a cost-effective way to "test drive" the Covaris AFA technology."

The Covaris technology foundation is its proprietary and patented AFA (Adaptive Focused Acoustics(TM)) technology. The Covaris AFA technology enables numerous non-contact, isothermal processes to be developed, for use in a broad range of applications in Genomics, Proteomics and Drug Discovery research, which could not be obtained prior to the development of AFA technology.

The DNA shearing service is a nice alternative sample prep tool for next-gen sequencing customers. In addition, Covaris is introducing eCommerce capability on Covaris website. This will enable customers to order commonly used consumables directly online.

About Covaris, Inc.

Covaris, Inc. is a rapidly growing life science instrument company. Its proprietary instrument platform, based on patented Adaptive Focused Acoustic (AFA) technology brings unsurpassed speed and efficiency to biological and chemical sample preparation. The AFA process, based on shock wave physics, delivers controlled, precise and accurate energy to biological and chemical samples. The process is non-contact, isothermal, and rapid. Leading pharmaceutical and biotechnology companies worldwide are using Covaris instruments for RNA extraction, Compound Dissolution, Drug Metabolism tissue extraction, and much more.

Information about Covaris is available at http://www.covarisinc.com.


'/>"/>
SOURCE Covaris Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Heavenly Essence Introduces Pureity - the Only Line of Hair Care Products That Really Cares About You
2. Schreiner ProTech Introduces Intelligent Marking Solutions Achieving Process and Cost Optimizations
3. Bipartisan Policy Center Founder Bob Dole Introduces Governor Sebelius at Confirmation Hearing to Be Next HHS Secretary
4. Zix Corporation Introduces Powerful New Version of PocketScript
5. Oxford Performance Materials Introduces OXPEKK Colored Compounds
6. Epson Introduces Color On Demand Inkjet Printer
7. Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit
8. Vinpower Digital Introduces the Industry's First Standalone Networkable Duplication Tower
9. Biogel Introduces Polyisoprene (PI) Indicator Underglove
10. Intergraph(R) Introduces SmartPlant(R) for Life Sciences
11. Ziehm Imaging Introduces Ziehm Solo C-arm, Featuring a Versatile set-up in the OR and Exceptional Image Quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: